Correlation Between Ardelyx and BioLineRx
Can any of the company-specific risk be diversified away by investing in both Ardelyx and BioLineRx at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Ardelyx and BioLineRx into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Ardelyx and BioLineRx, you can compare the effects of market volatilities on Ardelyx and BioLineRx and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Ardelyx with a short position of BioLineRx. Check out your portfolio center. Please also check ongoing floating volatility patterns of Ardelyx and BioLineRx.
Diversification Opportunities for Ardelyx and BioLineRx
Very good diversification
The 3 months correlation between Ardelyx and BioLineRx is -0.43. Overlapping area represents the amount of risk that can be diversified away by holding Ardelyx and BioLineRx in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on BioLineRx and Ardelyx is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Ardelyx are associated (or correlated) with BioLineRx. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of BioLineRx has no effect on the direction of Ardelyx i.e., Ardelyx and BioLineRx go up and down completely randomly.
Pair Corralation between Ardelyx and BioLineRx
Given the investment horizon of 90 days Ardelyx is expected to generate 0.54 times more return on investment than BioLineRx. However, Ardelyx is 1.85 times less risky than BioLineRx. It trades about 0.0 of its potential returns per unit of risk. BioLineRx is currently generating about -0.15 per unit of risk. If you would invest 525.00 in Ardelyx on December 30, 2024 and sell it today you would lose (32.00) from holding Ardelyx or give up 6.1% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Ardelyx vs. BioLineRx
Performance |
Timeline |
Ardelyx |
BioLineRx |
Ardelyx and BioLineRx Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Ardelyx and BioLineRx
The main advantage of trading using opposite Ardelyx and BioLineRx positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Ardelyx position performs unexpectedly, BioLineRx can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BioLineRx will offset losses from the drop in BioLineRx's long position.Ardelyx vs. BioLineRx | Ardelyx vs. Lexicon Pharmaceuticals | Ardelyx vs. Seres Therapeutics | Ardelyx vs. Immunitybio |
BioLineRx vs. Ardelyx | BioLineRx vs. Lexicon Pharmaceuticals | BioLineRx vs. Seres Therapeutics | BioLineRx vs. Immunitybio |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..
Other Complementary Tools
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
CEOs Directory Screen CEOs from public companies around the world | |
Equity Valuation Check real value of public entities based on technical and fundamental data |